{
  "patient_id": "PT-005",
  "first_name": "Aisha",
  "last_name": "Patel",
  "demographics": {
    "first_name": "Aisha",
    "last_name": "Patel",
    "date_of_birth": "2022-05-18",
    "age": 3,
    "gender": "female",
    "weight_kg": 13.5
  },
  "diagnosis": {
    "primary": "Spinal Muscular Atrophy - Presymptomatic",
    "icd10": "G12.1",
    "onset_date": "2023-01-15",
    "genetic_confirmation": true,
    "smn1_deletion": true,
    "smn2_copy_number": 5,
    "notes": "Newborn screening identified presymptomatic SMA with 5 SMN2 copies. Historically, 5-copy patients were excluded under prior BCBS policy because the asymptomatic pathway required 2-3 copies."
  },
  "clinical_status": {
    "ambulatory": true,
    "ventilator_dependent": false,
    "permanent_ventilator": false,
    "motor_milestone_score": null,
    "baseline_motor_score": null,
    "clinical_improvement": null,
    "symptomatic": false,
    "prior_gene_therapy": false,
    "concurrent_risdiplam": false,
    "enrolled_in_clinical_trial": false
  },
  "treatment_history": {
    "current_medication": "nusinersen",
    "treatment_start_date": "2023-04-01",
    "doses_received": 6,
    "last_dose_date": "2025-04-15",
    "prescriber_specialty": "pediatric_neurology"
  },
  "insurance": {
    "primary": {
      "payer_name": "bcbs",
      "plan_type": "PPO",
      "member_id": "BCB-2023-78543",
      "group_number": "GRP-4410"
    }
  },
  "medication_request": {
    "medication_name": "nusinersen",
    "brand_name": "spinraza",
    "route": "intrathecal",
    "request_type": "continuation",
    "prior_authorization_status": "approved",
    "approval_date": "2025-01-15",
    "expiration_date": "2026-01-15"
  }
}
